Jones Financial Companies’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$701K Buy
7,324
+143
+2% +$14.7K ﹤0.01% 2064
2026
Q1
$766K Buy
7,181
+40
+0.6% +$3.81K ﹤0.01% 1834
2025
Q4
$579K Sell
7,141
-345
-5% -$29.7K ﹤0.01% 1450
2025
Q3
$630K Buy
7,486
+158
+2% +$14.1K ﹤0.01% 1301
2025
Q2
$605K Buy
7,328
+60
+0.8% +$5.01K ﹤0.01% 1199
2025
Q1
$604K Buy
7,268
+281
+4% +$26.1K ﹤0.01% 1044
2024
Q4
$644K Buy
6,987
+187
+3% +$18K ﹤0.01% 892
2024
Q3
$624K Hold
6,800
﹤0.01% 744
2024
Q2
$560K Buy
+6,800
New +$500K ﹤0.01% 537

Other funds holding LMAT

Jones Financial Companies's LMAT Position: Q2 2026 in Review

Jones Financial Companies increased its LeMaitre Vascular (LMAT) stake by 2% in Q2 2026, buying an estimated $14.7K and bringing the position to 7,324 shares worth $701K. The position accounts for ﹤0.01% of the portfolio, ranked #2064.

Jones Financial Companies first reported a position in LMAT in Q2 2024 and has held it in 9 quarters since. The position peaked at $766K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Jones Financial Companies held 7,324 shares of LeMaitre Vascular worth $701K as of Q2 2026.
  • Jones Financial Companies bought 143 LeMaitre Vascular shares in Q2 2026, an estimated $14.7K.
  • LeMaitre Vascular made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2064 holding.
  • Jones Financial Companies first reported a position in LeMaitre Vascular in Q2 2024 and has held it in 9 quarters since.
  • Jones Financial Companies's LeMaitre Vascular position peaked at $766K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.